Sanofi Escalates Legal Fight for HRSA 340B Contract Pharmacy Records Amid Controversial Rebate Push

Sanofi is suing HRSA in federal court to release thousands of 340B contract pharmacy agreements.
Pharmaceutical giant Sanofi has intensified its legal battle seeking the release of extensive 340B contract pharmacy records after announcing plans [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA Sends New York Times More Documents Requested in 340B FOIA Lawsuit

U.S. Attorney Damian Williams updated a federal judge on the status of HRSA’s agreement to process the New York Times' requests for records.
The U.S. Health and Human Services Department has sent the New York Times hundreds of 340B-related documents and emails that [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Fourth Large Manufacturer Fights to Establish Contested 340B Rebate Model

BMS sued the federal government Nov. 26 to unilaterally establish a 340B rebate model.
Pharmaceutical giant Bristol-Myers Squibb (BMS) sued the federal government late Tuesday to establish a 340B rebate model, joining at least [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Weekly Roundup: Arkansas SCOTUS Appeal and Updates in West Virginia, Mississippi

Key briefs were filed this week in litigation over state contract pharmacy access laws in Arkansas, West Virginia and Mississippi.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Hospital Systems Fight HRSA’s Threat to Remove Them from 340B Program Over J&J Audits

Three 340B hospital systems are seeking temporary restraining orders against HRSA in the U.S. District Court for the District of Columbia.
Three large hospital systems are asking a federal court to immediately block the government from removing them from the 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Weekly Roundup: Updates in Mississippi, Missouri

Key briefs were filed this week in state contract pharmacy litigation in Mississippi and Missouri.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HHS Fights Sanofi’s FOIA Lawsuit Seeking Extensive 340B Contract Pharmacy Records

HHS responded in court to Sanofi's FOIA lawsuit seeking government records of 340B contract pharmacy agreements.
The federal government is pushing back against Sanofi’s lawsuit demanding the release of up to 7,500 records of 340B contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

PhRMA Dismisses Lawsuit Challenging 340B ADR Rule

A Maryland federal judge granted PhRMA's request to dismiss its challenge to the government's 340B ADR process.
A Maryland federal judge recently granted an influential drug industry trade group’s request to dismiss its 2021 lawsuit challenging a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Breaking News

Lilly Sues HHS, HRSA to Implement Expansive 340B Rebate for All Products and Covered Entity Types

Lilly filed a Nov. 14 lawsuit against HHS and HRSA for blocking its proposed 340B rebate model with Kalderos.
Eli Lilly on Thursday sued the federal government to implement a sweeping 340B rebate model that would apply to all [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

J&J Lawsuit to Test Trump Administration’s Stance on 340B Rebates

J&J sued HRSA on Nov. 12 for threatening enforcement action that led the drugmaker to withdraw its 340B rebate proposal.
Johnson & Johnson’s (J&J’s) lawsuit challenging the federal government’s opposition to 340B rebates will test whether the Trump administration is [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live